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Abstract

Obstructive sleep apnea (OSA) is a common cause of high blood pressure but often
undetected in patients with hypertension. Screening tools for OSA exist but are underutilized.
This project aimed to identify current practices and perceptions related to screening for OSA in
patients with hypertension and improve primary care provider knowledge of OSA and screening
rates using the STOP-BANG screening tool. The providers acknowledged the importance of
screening patients with hypertension but there was no increase in screening after education was
provided. Effective screening tools exist but effective strategies to bring this evidence to practice
need to be explored further.

Keywords: Obstructive sleep apnea, STOP-BANG, hypertension, screening tools, primary care.
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Screening Patients with Hypertension for Sleep Apnea using the STOP-BANG Screening Tool in
a Primary Care Setting

Introduction
It is estimated that 22 million Americans suffer from sleep apnea, with as much as 80
percent of cases of moderate and severe obstructive sleep apnea being undiagnosed (American
Sleep Apnea Association, 2015). One screening tool that should be considered in the primary
care office is the STOP-BANG screening tool that would elicit potential patients who are
suffering from sleep apnea. Sleep apnea can exacerbate many cardiovascular and cerebrovascular
conditions and cause events such as myocardial infarction and stroke. Nurse practitioners should
be aware of the potential consequences of undiagnosed sleep apnea and the ramifications that
could occur. Sleep apnea is a secondary cause of hypertension and often goes undetected. STOPBANG is an evidence-based screening tool that is brief and easy to use in a primary care setting.
Background
Sleep apnea is defined as a common sleep disorder characterized by repetitive episodes of
apnea and hypopnea during sleep (Chung F., Yang, Y., & Liao, P., 2013). This condition is a
common disorder that increases the risk for high blood pressure, heart attack, stroke,
arrhythmias, heart failure, obesity, and diabetes (NIH, 2012). Obstructive sleep apnea is a
secondary cause of hypertension, and is directly related to target-organ damage and increased
markers of atherosclerosis (Drager, L., et al. 2016). According to the CDC, 1 in 3 Americans, or
about 75 million individuals, suffer from hypertension. Kentucky has numbers consistent with
the national average and hypertension rates have continued to rise since 1996 (CDC, 2013). This
equates to a healthcare expenditure of $48.6 billion dollars annually (CDC, 2016). Additionally,

2

Kentucky alone reported in 2009 that 34.9% of adults report insufficient sleep fourteen out of
thirty days per month (CDC, 2016).
An estimated 50% of patients with hypertension have concomitant OSA (Konecny, T.,
Kara, T., Somers, V.K. 2014). The mechanism of action that occurs is that an apneic episode
produces surges in systolic and diastolic pressure that keep mean blood pressure levels elevated
at night. These increases in pressure can also remain present during the daytime (Dopp, J.M.,
Reichmuth, K.J., Morgan, B.J., 2007). With 75 million Americans with hypertension and half of
them having OSA, this means that there are about 37.5 million patients with sleep apnea. If 80%
are undiagnosed then there are approximately 30 million patients that are not being treated for
their sleep apnea.
Screening tools exist to help detect sleep apnea but are often not used. The STOP-BANG
screening tool, originally developed for use in the surgical setting, is one example of an
assessment tool that is useful for detection of sleep apnea problems (Chung F., Yang, Y., & Liao,
P., 2013. Although developed for surgical patients, studies have demonstrated that this tool is
effective in primary care as well (Keshava, K., et al. 2014).The STOP-BANG screening tool has
a sensitivity of 87 percent. (Silva, G., et al., 2011). Studies have demonstrated that a STOPBANG score of 7 or higher was indicative of sleep apnea 100% of the time (Keshava, K., et al.,
2014). The eight-part questionnaire has a dichotomous answer of yes or no that allows for ease in
scoring and determining the risk of each patient after administration. The questions are easily
remembered with the mnemonic STOP-BANG which stands for snoring, tired, observed apnea,
pressure or hypertension, BMI, age, neck circumference, and gender. In the primary care setting
where time is limited, evidence supports the effectiveness and efficiency of this tool in driving
the direction of care.
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In spite of the evidence that exists, sleep apnea still remains an underdiagnosed and
undertreated problem, leading to significant consequences. Due to the alarming statistics
surrounding sleep apnea and its relation to hypertension, it is clear that an emphasis should be
placed on screening patients so that the appropriate care can be administered. By implementation
of the STOP-BANG screening tool for patients with hypertension, providers can improve health
outcomes through the detection of an underlying disorder and may be able to reduce patient
morbidity and mortality.
Purpose
The purpose of this study was to assess baseline practices related to screening for
obstructive sleep apnea (OSA) among adult patients with hypertension in a primary care setting.
Furthermore, the purpose was to educate providers about sleep apnea and the STOP-BANG
screening tool and to evaluate subsequent changes in knowledge and screening rates.
Methods
This pilot study was a quasi-experimental study to assess the feasibility of methods and
initial effects of the intervention to improve screening for OSA among patients diagnosed with
hypertension. Institutional review board approval was obtained.
Setting and Sample: This study took place in a Norton Healthcare primary care setting in
Louisville, Kentucky. There were three sample groups. First, there was the pre-implementation
patient chart group. A power analysis concluded that the point of reaching saturation would be
100 charts. Inclusion criteria for the pre-implementation charts were that the patient was between
the ages of 18 and 70 years old and had been treated for hypertension or an ICD 10 code I10 by
any of the providers in the specific office chosen. Next, 100 charts were randomly selected using
4

a random number generator in Excel. These charts were dated between January 1, 2016, and
December 31, 2016. Secondly, there was a group of providers that voluntarily participated and
were consented to be a part of the study. Providers were eligible based on being physicians,
nurse practitioners or physician assistants employed in the chosen setting. These providers
delivered care to patients with hypertension and were willing to receive education on the STOPBANG screening tool and utilize the tool in their practice. This educational intervention occurred
on May 31, 2017. Lastly, for the post-implementation phase, patients charts for review were
chosen based on being a patient of one of the consented providers and had an office visit for
hypertension or an ICD 10 code I10 and were between the ages 18 to 70. The random number
generator in Excel randomly selected 100 patients’ charts to be reviewed. The charts were
reviewed after the conclusion of the 3 month period between June 1, 2017, and August 30, 2017.
Procedures: To conduct a needs assessment, a retrospective chart review was completed
to assess the selected office providers’ current practices in regards to a screening of patients with
hypertension for OSA. Providers were given a questionnaire to complete that elicited their
current knowledge and perceptions regarding sleep apnea and the use of sleep apnea screening
tools. This survey included 4 multiple choice questions to test their knowledge and 13 Likertstyle questions to assess their perceptions, current practices, and barriers revolving around sleep
apnea. Next, the study was explained and education was given to the participating providers in a
face to face manner. This education included information on how to administer and score the
STOP-BANG tool and what criteria warranted a referral for polysomnography. Participants were
encouraged to use the tool and were informed that a retrospective chart review would be
conducted at the conclusion of the three-month implementation phase. During implementation,
consented providers conducted visits with their normal patient population and when a patient met
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the inclusion criteria they were to use the STOP-BANG screening tool to assess for sleep apnea.
The STOP-BANG tool was printed on paper and supplied for providers to score their patients
and the medical assistant scanned the form into the EMR. After the three-month timeframe was
complete, a retrospective chart review was completed on the three consenting providers and their
patients that were seen for hypertension. Audit tools were used in both chart reviews to ensure
consistency. At the conclusion of the study, the providers were provided with a post-survey that
was replicated from the pre-implementation survey to assess their knowledge and perceptions
after the implementation concluded.
Data Analysis
A descriptive statistical analysis was performed. For the demographic information, the
means and standard deviations were reported for the age and BMI, while frequency distribution
was reported for the gender of the patients included in the charts reviewed. Pearson’s chi-squared
test and the Fisher’s exact test were used to test for associations among categorical variables. The
Mann-Whitney U test was performed to test for differences in the potential STOP-BANG scores
between the pre and post cohorts because they were skewed. Statistical analyses were done using
the SPSS program with an alpha level of 0.05 throughout.
Results
There were eight possible provider candidates and all were approached. Seven providers
were physicians and one was a physician assistant. There were six providers that were female
and two male providers. Three providers consented to take part in the study, two male providers,
and one female provider, while five female providers declined. The three providers were all
physicians with experience ranging from 6-26 years. The pre and post provider questionnaires
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were given to the three participating providers. The first four questions assessed the knowledge
of the providers and information about sleep apnea as well as the STOP-BANG tool (see Table
1). For the first question, there was a deficit of knowledge about the undiagnosed patients as
none of the providers answered correctly. In the post phase, only one provider was able to retain
information that was taught in the educational intervention. The physiology behind how sleep
apnea and hypertension were related elicited a correct response from all providers in the preintervention phase but was changed in the post phase as one respondent answered incorrectly.
There was an increase of knowledge observed in question three. All providers were able to
correctly answer the question about scoring the STOP-BANG tool in the pre and post
implementation phases. Overall, the average score for all of the providers increased by 8.34%.
Two of the providers increased their knowledge while one provider’s knowledge decreased and
potentially was not able to retain information from the educational intervention (see Table 2).
Table 1. Provider Knowledge Responses
Questions
1. About what
percentage of patients
with OSA remain
undiagnosed?
a. 20%
b. 40%
c. 60%
d. 80%
2. When patients have
apneic episodes this
causes
a. Blood
pressures to
surge only at
night time.
b. Blood
pressures to
surge which

Pre Response

Post Response

1/3
1/3
3/3
1/3

1/3

3/3
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2/3

continues to be
apparent
during the
daytime.
c. Blood
pressures to
surge only
during the
daytime.
d. Nothing
happens to
blood
pressure.
3. The letter “O” in
STOP-BANG stands
for?
a. Overweight
b. Obese
c. Over the age
of 50
d. Observed
apnea
4. A score of 4 on the
STOP-BANG
screening tool
suggests?
a. No Risk of
OSA
b. Mild Risk of
OSA
c. Moderate Risk
of OSA
d. Severe Risk of
OSA

1/3
2/3

1/3

2/3

3/3

3/3
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Table 2. Provider Knowledge Scores
Providers
1
2
3
Averages

Pre Score
75%
50%
50%
58.33%

Post Score
25%
75%
100%
66.67%

The perceptions of providers were also assessed with a pre and post implementation
survey that addressed their current perceptions, practices, and barriers to screening. All providers
agreed and acknowledged that OSA has an impact on cerebrovascular and cardiovascular
systems and that screening patients with hypertension is important. One provider changed in the
post to agreeing that all patients with hypertension should be screened for OSA. In the preimplementation phase, one provider did not feel that there was a valid and reliable screening tool
but this changed after the intervention. Again, all providers in the pre and post phases were
comfortable with screening patients for OSA. In the pre-implementation, none of the providers
reported using any screening tools and in the post self-reported an increase in the use of the
STOP-BANG tool. Finally, perceptions of these three providers related to the reason screenings
did not occur was simply that there was lack of clinical time to complete a screening most of the
time. Non-compliance of patients and lack of reimbursement were also factors in why screenings
did not occur.
The demographic information from the charts that were reviewed were a part of the
STOP-BANG screening tool and include age, gender, and BMI. In the pre-implementation
group, there were 100 charts reviewed that met the inclusion criteria. The mean age was 58.5
years old (SD= 10.2) and 89% were females. The average BMI was 33.7. In the postimplementation charts, there were 100 charts reviewed that met inclusion criteria. The average
age was 56.5 years old (SD= 9.1) and 58% were males. The mean BMI was 33.5 (see Table 3).
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Age was similar for both groups but gender distribution was significantly different with a shift
from mostly females to a more even split with the majority being males.
Table 3. Descriptive statistics of the study samples

Age
Sex
Male
Female
BMI

Pre N=100

Post N=100

Mean (SD) or %
58.5 (10.2)

Mean (SD) or %
56.5 (9.1)

11%
89%

58%
42%

33.7 (7.1)

33.5 (6.9)

p
0.14
<.001

0.82

Data that was extracted from the chart reviews included questions that would be reviewed
from administering the STOP-BANG screening tool. Overall, there were only 2% of people
screened with STOP-BANG in the pre and 7% in the post phase (see Table 4).
Table 4. Audit tool for chart reviews

Screened with STOPBANG
Yes
No
Snoring
No
Yes
Not Assessed
Tired
No
Yes
Not Assessed
Apnea
No
Yes
Not Assessed

Pre N=100

Post N=100

p

2%
98%

7%
93%

0.09

1%
28%
71%

1%
37%
62%

0.40

3%
35%
62%

5%
37%
58%

0.71

3%
19%
78%

14%
20%
66%

0.01
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As there was no increase in the use of the STOP-BANG tool the primary investigator
determined potential scores that would have been elicited if the STOP-BANG tool had been
performed using information that was found in the patient’s chart. Scores ranged between one
and seven with a median of three in both phases of the study (see Table 5). For patients in the
post-implementation phase, 27% had potential scores that would be considered high risk that
would need further evaluation by polysomnography or a referral to a pulmonologist. Twenty-two
percent of patients scored a four on the STOP-BANG tool and would be considered moderate
risk. More clinical information would need to be determined by asking all of the questions in the
STOP-BANG tool as they may score higher if more information was available. Overall, in the
post-implementation phase, there are 78% of these patients that if screened may have warranted
polysomnography. The pre-implementation phase was similar with 58% of patients needing
further evaluation. Potential STOP-BANG scores can be found in Table 6.

Table 5. Mann-Whitney U test for STOP-BANG scores
Median
Pre
Post
p= 0.002

3
3

Lower
Quartile
2
3

Upper
Quartile
4
5

11

Minimum

Maximum

1
1

7
7

Table 6. Potential STOP-BANG scores
LOW RISK FOR
OSA
MODERATE RISK
HIGH RISK

STOP-BANG Scores
1

Pre n=100
5%

Post n=100
2%

2
TOTAL %
3
4
TOTAL %
5
6
7
8
TOTAL %

37%
42%
28%
12%
40%
10%
6%
2%
0%
18%

20%
22%
29%
22%
51%
11%
11%
5%
0%
27%

Discussion
The results did not show a significant difference in the implementation of the use of the
STOP-BANG screening tool. There were two patients out of one hundred screened in the preimplementation phase, one of which was done by a provider outside of the primary care office.
The other screening was done by a provider in the selected primary care office. In the post cohort
of this study, there were seven patients that were screened using the STOP-BANG tool. Of the
seven patients, five patients scored as high risk for sleep apnea and two were considered
moderate risk. Of the five that were considered high risk, three were appropriately referred for
sleep studies. For the moderate risk patients, the provider would need to refer based on their
clinical judgment on factors such as comorbidities.
When looking at elements that were not assessed, 62% of patients were not assessed for
snoring, 58% were not assessed for being tired, and 66% were not assessed for having any
observed apnea. These scores account for the 80% of people who are undiagnosed. While not all
of these patients would have sleep apnea or be at risk for sleep apnea there were many patients
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that were scored as a 4 which is considered a moderate risk that needs more information obtained
by asking the questions from the STOP-BANG tool. It is likely that many would fall into a
higher risk group. For patients in the post-implementation phase, there were 22% of patients that
scored a 4. Many of these patients would be considered as a missed opportunity because if the
provider had gotten more information then they might have become a 5 and be now considered
as a high-risk patient. Many patients would be able to tell you if they snored or if they do not feel
rested or are tired during the day although observed apnea may be harder to know unless there is
a partner sleeping next to the patient to help answer this question. Assessing all risk factors and
elements of the STOP-BANG tool is essential to elicit a score to determine the risk for sleep
apnea.
There were no potential STOP-BANG scores of a maximum score of 8 because 96% of
patients did not have a documented neck circumference. Many of the patients who received a
score of 7 may have been an 8 if there was one documented. Neck circumference is also a missed
opportunity for many of the patients that scored a 4 on their STOP-BANG screening as this may
have bumped them into the high-risk category. Many patients who were obese and would get a
point for this would also get a point for their larger neck sizes. Knowing this piece of information
would also help to identify those who are more a high risk.
Limitations
Limitations that were identified in this study include a small sample size, study design,
and the educational intervention. There were only three providers that participated in this study.
Assessing their knowledge and perceptions gives us a narrow view of all providers as this may
vary. Also, evaluating only one practice site makes it difficult to generalize the results from this
study to other potential practices.
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The study design is also a limitation in that additional information should have been
extracted from the charts. Discussing other comorbidities such as myocardial infarction and
stroke would place a larger emphasis on the importance of screening patients with OSA. This
could also be used as a marker for more patient populations that should be screened in the
primary care setting.
Finally, the educational intervention is a limitation due to the fact that there should have
been multiple modes of content delivery to enhance the retention rates of the education provided.
Education was given in a face to face manner. Handouts should be considered as well as a teachback method to make sure that the information was heard and received by the participants. Also,
the intervention should have had better reinforcement. In this study, the primary investigator
visited the site at the midway mark to check to see if there was any additional information
needed for screening patients. During this time, education was reinforced verbally. The timing of
the follow-up education was done at the beginning of the day before patients were seen or in
between patients individually with each of the participating providers. Determining what time
was best for the providers to hear this information may have helped them be more engaged.
Practice Implications
Patients with hypertension need to be screened for sleep apnea. This study showed the
feasibility of the use of the STOP-BANG tool and that providers are open to this screening
method. There currently is no specific tool that has been adopted by the healthcare organization.
This needs to occur in order for all providers to know what the standard for their organization is
surrounding sleep apnea. With the adoption of one tool, there also needs to be a specific place to
document this information as there is currently no template in the electronic medical record. This
makes it difficult to document and keep track of what screenings have been performed.
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Anesthesia providers currently use the STOP-BANG tool in the perioperative setting. Once they
have documented a score it is not easily seen or transferred into the primary care setting for
further evaluation. By adopting one tool and having a specific place to document this transfer of
information may increase diagnosis of sleep apnea in patients.
Finally, this screening tool should be performed on patients at their annual well visits. In
this study, the screening was to take place at any appointment where a patient’s hypertension
may have been addressed. With many competing priorities the screening tool may have been left
out due to lack of time to address all of the patient’s needs. At annual well visits, many other
screening tools are addressed and this could be an addition to those to ensure that it is performed.
Conclusion
Sleep apnea is an essential disease process that needs to be screened for in the primary
care setting. Results of this study indicate that providers concur with the importance of screening
and are conscious of the tie between sleep apnea and hypertension. Overall, this study did not
improve screening rates of sleep apnea and had poor compliance of screening patients. However,
providers acknowledged the importance of screening patients with hypertension, were open to
using a screening tool and showed potential. Effective screening tools exist but effective
strategies to bring this evidence to practice need to be explored further.
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